California State Teachers Retirement System (CalSTRS)’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.06K Buy
+660
New +$1.71K ﹤0.01% 2752
2025
Q2
– Sell
-1,476
Closed -$1.8K – 3042
2025
Q1
$1.8K Hold
1,476
– – ﹤0.01% 3023
2024
Q4
$1.9K Hold
1,476
– – ﹤0.01% 3048
2024
Q3
$4.06K Hold
1,476
– – ﹤0.01% 3029
2024
Q2
$3.34K Buy
+1,476
New +$4.48K ﹤0.01% 3049
2021
Q2
– Sell
-56,068
Closed -$122K – 3154
2021
Q1
$122K Hold
56,068
– – ﹤0.01% 3013
2020
Q4
$126K Sell
56,068
-7,062
-11% -$18.5K ﹤0.01% 2979
2020
Q3
$169K Hold
63,130
– – ﹤0.01% 2799
2020
Q2
$193K Hold
63,130
– – ﹤0.01% 2736
2020
Q1
$124K Buy
63,130
+713
+1% +$1.74K ﹤0.01% 2747
2019
Q4
$179K Hold
62,417
– – ﹤0.01% 2821
2019
Q3
$229K Buy
62,417
+12,765
+26% +$46.1K ﹤0.01% 2734
2019
Q2
$206K Buy
+49,652
New +$215K ﹤0.01% 2834
2015
Q2
– Sell
-35,331
Closed -$118K – 3013
2015
Q1
$118K Buy
35,331
+2,100
+6% +$7.5K ﹤0.01% 2968
2014
Q4
$115K Buy
33,231
+142
+0.4% +$628 ﹤0.01% 2992
2014
Q3
$166K Buy
33,089
+189
+0.6% +$1.47K ﹤0.01% 2942
2014
Q2
$454K Buy
+32,900
New +$410K ﹤0.01% 2556

Other funds holding GALT

California State Teachers Retirement System (CalSTRS)'s GALT Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) opened a new position in Galectin Therapeutics (GALT) in Q2 2026: 660 shares worth $3.06K. The stake represents ﹤0.01% of the portfolio and ranks #2752 among its holdings. This is a return to the name: California State Teachers Retirement System (CalSTRS) previously reported a position in GALT as recently as Q1 2025.

California State Teachers Retirement System (CalSTRS) first reported a position in GALT in Q2 2014 and has held it in 17 quarters since. The position peaked at $454K in Q2 2014. 98 funds tracked by Wall St. Rank hold GALT as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 660 shares of Galectin Therapeutics worth $3.06K as of Q2 2026.
  • Galectin Therapeutics was a new California State Teachers Retirement System (CalSTRS) position in Q2 2026.
  • Galectin Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2752 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Galectin Therapeutics in Q2 2014 and has held it in 17 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Galectin Therapeutics position peaked at $454K in Q2 2014.
  • 98 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.